2,599
Views
18
CrossRef citations to date
0
Altmetric
Diabetes

The accuracy of a non-invasive glucose monitoring device does not depend on clinical characteristics of people with type 2 diabetes mellitus

, &
Pages 1-7 | Received 09 Aug 2017, Accepted 05 Dec 2017, Published online: 11 Jan 2018

References

  • Bergenstal RM, Gavin JR. The role of self-monitoring of blood glucose in the care of people with diabetes: report of a global consensus conference. Am J Med. 2005;118:1–6.
  • Gagliardino JJ, Bergenstal R, Colagiuri S, et al. IDF Guideline on self-monitoring of blood glucose in non-insulin treated type 2 diabetes. Int Diabetes Fed. IDF Brus, Int Diabetes Fed. 2009.
  • American Diabetes Association. Standards of medical care in diabetes: 2016. Diabetes Care. 2016;29(Suppl 1):S1–S112.
  • Haller MJ, Stalvey MS, Silverstein JH. Predictors of control of diabetes: monitoring may be the key. J Pediatr. 2004;144:660–661.
  • Schütt M, Kern W, Krause U, et al. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24 500 patients from 191 centers in Germany and Austria. Exp Clin Endocrinol Amp Diabetes. 2006;114:384–388.
  • Towfigh A, Romanova M, Weinreb JE, et al. Self-monitoring of blood glucose levels in patients with type 2 diabetes mellitus not taking insulin: a meta-analysis. Am J Manag Care. 2008;14:468–475.
  • Karter AJ, Ackerson LM, Darbinian JA, et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry∗. Am J Med. 2001;111:1–9.
  • Heinemann L. Finger pricking and pain: a never ending story. J Diabetes Sci Technol. 2008;2:919–921.
  • Ong WM, Chua SS, Ng CJ. Barriers and facilitators to self-monitoring of blood glucose in people with type 2 diabetes using insulin: a qualitative study. Patient Prefer. Adherence. 2014;8:237–246.
  • Harman-Boehm I, Gal A, Raykhman AM, et al. Noninvasive glucose monitoring: a novel approach. J Diabetes Sci Technol. 2009;3:253–260.
  • Harman-Boehm I, Gal A, Raykhman AM, et al. Noninvasive glucose monitoring: increasing accuracy by combination of multi-technology and multi-sensors. J Diabetes Sci Technol. 2010;4:583.
  • Horman K, Mayzel Y, Gal A, et al. Performance and user experience evaluation of a non-invasive glucose monitoring device. Int J Diabetes Metab Disord. 2016;1:1–7.
  • Groenendaal W, von Basum G, Schmidt KA, et al. Quantifying the composition of human skin for glucose sensor development. J Diabetes Sci Technol. 2010;4:1032–1040.
  • Cengiz E, Tamborlane WV. A tale of two compartments: interstitial versus blood glucose monitoring. Diabetes Technol Ther. 2009;11(Suppl 1):S11–S16.
  • Stout PJ, Peled N, Erickson BJ, et al. Comparison of glucose levels in dermal interstitial fluid and finger capillary blood. Diabetes Technol Ther. 2001;3:81–90.
  • Cengiz E, Tamborlane WV. A tale of two compartments: interstitial versus blood glucose monitoring. Diabetes Technol Ther. 2009;11:S1–S11.
  • Koschinsky T, Jungheim K, Heinemann L. Glucose sensors and the alternate site testing-like phenomenon: relationship between rapid blood glucose changes and glucose sensor signals. Diabetes Technol Ther. 2003;5:829–842.
  • Bahartan K, Horman K, Gal A, et al. Assessing the performance of a non-invasive glucose monitor in people with type 2 diabetes with different demographic profiles. J Diabetes Res. 2017;2017:4393497.
  • Tan CY, Statham B, Marks R, et al. Skin thickness measurement by pulsed ultrasound: its reproducibility, validation and variability. Br J Dermatol. 1982;106:657–667.
  • Mast TD. Empirical relationships between acoustic parameters in human soft tissues. Acoust Res Lett Online. 2000;1:37–42.
  • Zoungas S, Woodward M, Li Q, et al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia. 2014;57:2465–2474.
  • Sabanayagam C, Liew G, Tai ES, et al. Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes? Diabetologia. 2009;52:1279–1289.
  • Sinha RN, Patrick AW, Richardson L, et al. A six-year follow-up study of smoking habits and microvascular complications in young adults with type 1 diabetes. Postgrad Med J. 1997;73:293–294.
  • Bergström J, Hultman E. Water, electrolyte and glycogen content of muscle tissue in patients undergoing regular dialysis therapy. Clin Nephrol. 1973;2:24–34.
  • Lederman SA, Paxton A, Heymsfield SB, et al. Body fat and water changes during pregnancy in women with different body weight and weight gain. Obstet Gynecol. 1997;90:483–488.
  • Zoungas S, Chalmers J, Ninomiya T, et al. Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia. 2012;55:636–643.
  • Miller VA, Kris MG, Shah N, et al. Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non–small-cell lung cancer. J Clin Oncol. 2004;22:1103–1109.
  • Kovatchev B, Anderson S, Heinemann L, et al. Comparison of the numerical and clinical accuracy of four continuous glucose monitors. Diabetes Care. 2008;31:1160–1164.
  • Clarke WL. The original Clarke Error Grid Analysis (EGA). Diabetes Technol Ther. 2005;7:776–779.
  • Halekoh U, Højsgaard S. A Kenward-Roger approximation and parametric bootstrap methods for tests in linear mixed models: the R package pbkrtest. J Stat Softw. 2014;59:1–32.
  • Bates D, Maechler M, Bolker B, et al. Fitting linear mixed-effects models using lme4. J Stat Softw. 2014;67:17487.
  • Lin T, Gal A, Mayzel Y, et al. Non-invasive glucose monitoring: a review of challenges and recent advances. Curr Trends Biomed Eng Biosci. 2017;6:1–8.
  • O’hare AM, Glidden DV, Fox CS, et al. High prevalence of peripheral arterial disease in persons with renal insufficiency results from the National Health and Nutrition Examination Survey 1999–2000. Circulation. 2004;109:320–323.